Robotic versus open distal gastrectomy for gastric cancer

Background: Gastrectomy with D2 lymphadenectomy is the gold standard for locally advanced gastric cancer (GC). While robotic surgery is established for early-stage GC, its oncological equivalence to open surgery in advanced stages remains debated in Western cohorts. This study compares perioperative safety and long-term outcomes between robotic distal gastrectomy (RDG) and open distal gastrectomy (ODG). Methods: This bicentric, retrospective study included 100 patients (RDG, n = 50; ODG, n = 50) treated between 2016 and 2024. The primary endpoint was overall survival (OS) at 1, 3, and 5 years. Secondary endpoints included perioperative outcomes, lymph node yield, postoperative complications, and length of hospital stay. Results: RDG had longer operative times (277.5 vs. 237.5 minutes, P < 0.001) but significantly lower blood loss (50 vs. 365 mL, P < 0.001) and transfusion rates (6.0% vs. 24.0%, P = 0.023). Oncological radicality was comparable: R0 rates (96.0% vs. 94.0%, P = 0.678) and lymph node yield (24.5 vs. 25.0, P = 0.809) showed no significant differences. RDG demonstrated shorter hospital stays (8 vs. 11 days, P < 0.001) and lower morbidity (26.0% vs. 50.0%, P = 0.023). Multivariate analysis showed that the surgical approach did not independently predict major complications (respiratory complications or duodenal stump leakage [DSL]). Age >75, Charlson Comorbidity Index ≥6, American Society of Anesthesiologists ≥3, and tumor, node, metastasis stage ≥III were identified as independent predictors for DSL. Long-term analysis revealed no significant difference in median OS (37.0 vs. 39.0 months, log-rank P = 0.820) or recurrence rates (24.0% vs. 28.0%). Conclusions: RDG is oncologically equivalent to ODG across all stages. Despite longer operative times, RDG offers lower morbidity and faster recovery, confirming it as a safe and effective therapeutic option. Our findings support adopting robotic surgery even for locally advanced GC in high-complexity Hub institutions.

Authors

Institutions

Publication Details

Journal
Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons
Published
2026-09-24
DOI
https://doi.org/10.1097/ia9.0000000000000092
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Robotic versus open distal gastrectomy for gastric cancer

Valerio Caracino, Piero Bazzi, Massimo Basti, Ettore Colangelo et al.
Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons
Gastric Cancer Management and Outcomes
article

Robotic versus open distal gastrectomy for gastric cancer

Valerio Caracino, Piero Bazzi, Massimo Basti, Ettore Colangelo, Pietro Coletta, Dario Zansavio, Marsia Tancredi
article en

Abstract

Background: Gastrectomy with D2 lymphadenectomy is the gold standard for locally advanced gastric cancer (GC). While robotic surgery is established for early-stage GC, its oncological equivalence to open surgery in advanced stages remains debated in Western cohorts. This study compares perioperative safety and long-term outcomes between robotic distal gastrectomy (RDG) and open distal gastrectomy (ODG). Methods: This bicentric, retrospective study included 100 patients (RDG, n = 50; ODG, n = 50) treated between 2016 and 2024. The primary endpoint was overall survival (OS) at 1, 3, and 5 years. Secondary endpoints included perioperative outcomes, lymph node yield, postoperative complications, and length of hospital stay. Results: RDG had longer operative times (277.5 vs. 237.5 minutes, P < 0.001) but significantly lower blood loss (50 vs. 365 mL, P < 0.001) and transfusion rates (6.0% vs. 24.0%, P = 0.023). Oncological radicality was comparable: R0 rates (96.0% vs. 94.0%, P = 0.678) and lymph node yield (24.5 vs. 25.0, P = 0.809) showed no significant differences. RDG demonstrated shorter hospital stays (8 vs. 11 days, P < 0.001) and lower morbidity (26.0% vs. 50.0%, P = 0.023). Multivariate analysis showed that the surgical approach did not independently predict major complications (respiratory complications or duodenal stump leakage [DSL]). Age >75, Charlson Comorbidity Index ≥6, American Society of Anesthesiologists ≥3, and tumor, node, metastasis stage ≥III were identified as independent predictors for DSL. Long-term analysis revealed no significant difference in median OS (37.0 vs. 39.0 months, log-rank P = 0.820) or recurrence rates (24.0% vs. 28.0%). Conclusions: RDG is oncologically equivalent to ODG across all stages. Despite longer operative times, RDG offers lower morbidity and faster recovery, confirming it as a safe and effective therapeutic option. Our findings support adopting robotic surgery even for locally advanced GC in high-complexity Hub institutions.

Il Giornale di Chirurgia - Journal of the Italian Association of Hospital SurgeonsVol. 46(3)
Ospedale di Santo Spirito (IT)
Good health and well-being
Openalex Percentile: Top 12%
Gastric Cancer Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.